CONMED 미래 성장

Future 기준 확인 1/6

CONMED (는) 각각 연간 7% 및 5.2% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 8.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 14.1% 로 예상됩니다.

주요 정보

7.0%

수익 성장률

8.8%

EPS 성장률

Medical Equipment 수익 성장	12.7%
매출 성장률	5.2%
향후 자기자본 수익률	14.1%
애널리스트 커버리지	Good
마지막 업데이트	01 May 2025

최근 미래 성장 업데이트

CONMED Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 08

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 02

Recent updates

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 31

Repeated Disappointments On Growth And Margins Leaves Conmed Even Deeper In The Doghouse

Feb 28

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Feb 28

CONMED Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 08

CONMED Corporation (NYSE:CNMD) Looks Inexpensive But Perhaps Not Attractive Enough

Jan 20

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 02

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Oct 01

Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

Sep 12

Orthopedic And General Surgery Innovations Propel Growth Despite Supply Chain Headwinds

Sep 10 CONMED's focus on resolving supply chain issues will likely bolster product availability, enhancing revenue growth in key segments.

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Aug 15

CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

Jul 17

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Jun 21

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Jun 01

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28

수익 및 매출 성장 예측

NYSE:CNMD - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2027	1,521	139	173	179	4
12/31/2026	1,438	125	147	150	7
12/31/2025	1,362	105	122	140	7
3/31/2025	1,316	119	165	179	N/A
12/31/2024	1,307	132	154	167	N/A
9/30/2024	1,288	132	166	180	N/A
6/30/2024	1,276	99	159	175	N/A
3/31/2024	1,262	82	142	158	N/A
12/31/2023	1,245	64	106	125	N/A
9/30/2023	1,169	58	38	57	N/A
6/30/2023	1,139	88	16	37	N/A
3/31/2023	1,099	-94	7	29	N/A
12/31/2022	1,045	-81	12	33	N/A
9/30/2022	1,069	-83	59	79	N/A
6/30/2022	1,042	-114	56	74	N/A
3/31/2022	1,020	68	74	90	N/A
12/31/2021	1,011	63	97	112	N/A
9/30/2021	989	62	83	98	N/A
6/30/2021	979	54	99	112	N/A
3/31/2021	881	13	70	83	N/A
12/31/2020	862	10	52	65	N/A
9/30/2020	874	0	69	85	N/A
6/30/2020	870	0	69	87	N/A
3/31/2020	951	34	84	103	N/A
12/31/2019	955	29	75	95	N/A
9/30/2019	933	29	60	79	N/A
6/30/2019	901	28	28	47	N/A
3/31/2019	876	31	29	46	N/A
12/31/2018	860	41	N/A	75	N/A
9/30/2018	840	72	N/A	71	N/A
6/30/2018	828	73	N/A	80	N/A
3/31/2018	812	71	N/A	75	N/A
12/31/2017	796	55	N/A	66	N/A
9/30/2017	778	15	N/A	58	N/A
6/30/2017	773	16	N/A	70	N/A
3/31/2017	769	12	N/A	72	N/A
12/31/2016	764	15	N/A	40	N/A
9/30/2016	750	16	N/A	36	N/A
6/30/2016	735	17	N/A	24	N/A
3/31/2016	722	22	N/A	17	N/A
12/31/2015	719	30	N/A	51	N/A
9/30/2015	723	34	N/A	64	N/A
6/30/2015	729	27	N/A	65	N/A
3/31/2015	736	30	N/A	63	N/A
12/31/2014	740	32	N/A	65	N/A
9/30/2014	747	31	N/A	67	N/A
6/30/2014	750	35	N/A	83	N/A

애널리스트 미래 성장 예측

수입 대 저축률: CNMD 의 연간 예상 수익 증가율( 7% )이 saving rate( 2.8% 보다 높습니다. ).

수익 vs 시장: CNMD 의 연간 수익( 7% ) US 시장( 13.9% 보다 느리게 성장할 것으로 예상됩니다. 13.9% 연간).

고성장 수익: CNMD 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: CNMD 의 수익(연간 5.2% ) US 시장( 8.4% 보다 느리게 성장할 것으로 예상됩니다. 8.4% 연간).

고성장 수익: CNMD 의 수익(연간 5.2% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: CNMD 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 14.1 %).

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2025/05/05 05:56
장 마감 주가	2025/05/02 00:00
수익	2025/03/31
연간 수익	2024/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처는 미국 증권의 예를 사용했습니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 Github에서 확인할 수 있습니다.

애널리스트 출처

CONMED Corporation 14 애널리스트 중 7 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Travis Steed	Barclays
Travis Steed	BofA Global Research
Kristen Stewart	CL King & Associates, Inc.

CONMED 미래 성장

Future 기준 확인 1/6

주요 정보

최근 미래 성장 업데이트

Conmed Corporation Revises Earnings Guidance for Full Year 2025

Price target decreased by 7.5% to US$74.43

Consensus EPS estimates fall by 15%

CONMED Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

CONMED Corporation Provides Financial Guidance for the First Quarter and Full Year of 2025

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Recent updates

First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Conmed Corporation Revises Earnings Guidance for Full Year 2025

Price target decreased by 7.5% to US$74.43

Investor sentiment deteriorates as stock falls 15%

CONMED Corporation, Annual General Meeting, May 20, 2025

CONMED Corporation to Report Q1, 2025 Results on Apr 30, 2025

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Repeated Disappointments On Growth And Margins Leaves Conmed Even Deeper In The Doghouse

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Fourth quarter dividend of US$0.20 announced

CONMED Corporation Appoints Mark Kaye to Its Board of Directors

Advisor notifies of intention to sell stock

Investor sentiment deteriorates as stock falls 16%

Consensus EPS estimates fall by 15%

CONMED Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS exceeds analyst expectations

CONMED Corporation Provides Financial Guidance for the First Quarter and Full Year of 2025

CONMED Corporation (NYSE:CNMD) Looks Inexpensive But Perhaps Not Attractive Enough

CONMED Corporation to Report Q4, 2024 Results on Feb 05, 2025

Is Now The Time To Look At Buying CONMED Corporation (NYSE:CNMD)?

CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Third quarter dividend of US$0.20 announced

CONMED Corporation Declares Quarterly Cash Dividend, Payable on January 3, 2025

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

President exercised options and sold US$570k worth of stock

CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Investor sentiment improves as stock rises 16%

New minor risk - Earnings quality

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

CONMED Corporation Announces Chief Executive Officer Changes

New minor risk - Earnings quality

Third quarter 2024 earnings: EPS exceeds analyst expectations

CONMED Corporation Announces Executive Changes

CONMED Corporation to Report Q3, 2024 Results on Oct 30, 2024

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

Orthopedic And General Surgery Innovations Propel Growth Despite Supply Chain Headwinds

Upcoming dividend of US$0.20 per share

CONMED Corporation Announces Termination of Stanley W. (Bill) Peters as President, Advanced Surgical & Advanced Endoscopic Technologies, Effective August 31, 2024

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Second quarter dividend of US$0.20 announced

Consensus EPS estimates increase by 10%, revenue downgraded

Price target decreased by 8.8% to US$84.25

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

CONMED Corporation to Report Q2, 2024 Results on Jul 31, 2024

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Insider notifies of intention to sell stock

Upcoming dividend of US$0.20 per share

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

First quarter dividend of US$0.20 announced

CONMED Corporation Declares Quarterly Cash Dividend, Payable on July 5, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

CONMED Corporation, Annual General Meeting, May 22, 2024

CONMED Corporation to Report Q1, 2024 Results on Apr 24, 2024

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Insider exercised options and sold US$721k worth of stock

Upcoming dividend of US$0.20 per share

CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Full year 2023 earnings: EPS misses analyst expectations

CONMED Corporation Provides Financial Guidance for the Full Year 2024

Investor sentiment deteriorates as stock falls 17%

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects